Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 855

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 855
---
. 001-41125, filed with the SEC on December 9, 2021). |
| 10.3    |     | Form of Registration Rights and Lock-Up Agreement (incorporated by reference to Exhibit 10.1 to APx Acquisition Corp. I’s Form 8-K, File No. 001-41125, filed with the SEC March 29, 2024).                                                                                                          |

II-1

| Exhibit 
 Number  |     | Description                                                                                                                                                                                                                                                                                                      |
| 10.4    |     | Backstop Agreement (incorporated by reference to Exhibit 10.3 to APx Acquisition Corp. I’s Form 8-K, File No. 001-41125, filed with the SEC March 29, 2024).                                                                                                                                                     |
| 10.5    |     | Amended and Restated Promissory Note by APx in favor of Templar LLC (incorporated by reference to Exhibit 10.2 to APx Acquisition Corp. I’s Form 8-K, File No. 001-41125, filed with the SEC March 29, 2024).                                                                                                    |
| 10.6    |     | Promissory Note by APx in favor of Bioceres, LLC (incorporated by reference to Exhibit 10.1 to APx Acquisition Corp. I’s Form 8-K, File No. 001-41125, filed with the SEC February 12, 2024).                                                                                                                    |
| 10.7    |     | IPO Letter Agreement, dated as of December 6, 2021, between SPAC, Initial Sponsor, Sponsor and Templar Subco (as amended on September 8, 2023 and March 21, 2024) (incorporated by reference to Exhibit 10.4 to APx Acquisition Corp. I’s Form 8-K, File No. 001-41125, filed with the SEC on February 7, 2024). |
| 10.8**  |     | Reseller License Agreement term sheet, dated as of August 11, 2024 between OmnigenicsAI and MultiplAI.                                                                                                                                                                                                           |
| 10.9**  |     | Commercialization Agreement, dated January 3, 2017, between Centro de Diagnóstico Médico de Alta Complejidad S.A. and Heritas SAU.                                                                                                                                                                               |
| 10.